BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35705834)

  • 41. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy.
    Hue JJ; Sugumar K; Markt SC; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
    Surgery; 2021 Jul; 170(1):207-214. PubMed ID: 33454134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minimally invasive versus open intersphincteric resection of low rectal cancer regardless of neoadjuvant chemoradiotherapy: long-term oncologic outcomes.
    Shin JK; Kim HC; Lee WY; Yun SH; Cho YB; Huh JW; Park YA
    Sci Rep; 2021 May; 11(1):11001. PubMed ID: 34040037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncologic outcomes after robot-assisted versus laparoscopic distal pancreatectomy: Analysis of the National Cancer Database.
    Raoof M; Nota CLMA; Melstrom LG; Warner SG; Woo Y; Singh G; Fong Y
    J Surg Oncol; 2018 Sep; 118(4):651-656. PubMed ID: 30114321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of oncologic outcomes between pancreaticoduodenectomy and total pancreatectomy for pancreatic adenocarcinoma.
    Zhu J; Jiang Z; Xie B; Fu C; Xiao W; Li Y
    Surg Endosc; 2023 Jan; 37(1):109-119. PubMed ID: 35851818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the perioperative complications and outcomes of robotic pancreaticoduodenectomy using the National Cancer Database: is it ready for prime time?
    Aziz H; Khan M; Khan S; Serra GP; Goodman MD; Genyk Y; Sheikh MR
    J Robot Surg; 2022 Jun; 16(3):687-694. PubMed ID: 34398365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimally invasive pancreatoduodenectomy: is the incidence of clinically relevant postoperative pancreatic fistula comparable to that after open pancreatoduodenectomy?
    Kantor O; Pitt HA; Talamonti MS; Roggin KK; Bentrem DJ; Prinz RA; Baker MS
    Surgery; 2018 Mar; 163(3):587-593. PubMed ID: 29454444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma.
    Mehtsun WT; McCleary NJ; Maduekwe UN; Wolpin BM; Schrag D; Wang J
    JAMA Oncol; 2022 Jan; 8(1):88-95. PubMed ID: 34854874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bridging the gap between open and minimally invasive pancreaticoduodenectomy: the hybrid approach.
    Wang Y; Bergman S; Piedimonte S; Vanounou T
    Can J Surg; 2014 Aug; 57(4):263-70. PubMed ID: 25078932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy.
    Zureikat AH; Postlewait LM; Liu Y; Gillespie TW; Weber SM; Abbott DE; Ahmad SA; Maithel SK; Hogg ME; Zenati M; Cho CS; Salem A; Xia B; Steve J; Nguyen TK; Keshava HB; Chalikonda S; Walsh RM; Talamonti MS; Stocker SJ; Bentrem DJ; Lumpkin S; Kim HJ; Zeh HJ; Kooby DA
    Ann Surg; 2016 Oct; 264(4):640-9. PubMed ID: 27433907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
    Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
    Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
    Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
    J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study.
    Kamarajah SK; Naffouje SA; Salti GI; Dahdaleh FS
    Ann Surg Oncol; 2021 Apr; 28(4):1896-1905. PubMed ID: 33398644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncologic Outcomes of Robotic Left Pancreatectomy for Pancreatic Adenocarcinoma: A Single-Center Comparison to Laparoscopic Resection.
    Baimas-George M; Watson M; Salibi P; Tschuor C; Murphy KJ; Iannitti D; Baker E; Ocuin L; Vrochides D; Martinie JB
    Am Surg; 2021 Jan; 87(1):45-49. PubMed ID: 32915060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma.
    Xiong J; Wei A; Ke N; He D; Chian SK; Wei Y; Hu W; Liu X
    Int J Surg; 2017 Dec; 48():134-141. PubMed ID: 29081373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. National Trends in Postoperative Outcomes and Cost Comparing Minimally Invasive Versus Open Liver and Pancreatic Surgery.
    Okunrintemi V; Gani F; Pawlik TM
    J Gastrointest Surg; 2016 Nov; 20(11):1836-1843. PubMed ID: 27613735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.
    Renz BW; Khalil PN; Mikhailov M; Graf S; Schiergens TS; Niess H; Boeck S; Heinemann V; Hartwig W; Werner J; Bruns CJ; Kleespies A
    Int J Surg; 2016 Apr; 28():118-25. PubMed ID: 26906329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database.
    Hamad A; Underhill J; Ansari A; Thayaparan V; Cloyd JM; Li Y; Pawlik TM; Tsung A; Abushahin L; Ejaz A
    Surgery; 2022 Jun; 171(6):1464-1470. PubMed ID: 35115154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does Major Pancreatic Surgery Have Utility in Nonagenarians with Pancreas Cancer?
    Meltzer RS; Kooby DA; Switchenko JM; Datta J; Carpizo DR; Maithel SK; Shah MM
    Ann Surg Oncol; 2021 Apr; 28(4):2265-2272. PubMed ID: 33141373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minimally invasive surgical approaches offer earlier time to adjuvant chemotherapy but not improved survival in resected pancreatic cancer.
    Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
    Surg Endosc; 2018 May; 32(5):2387-2396. PubMed ID: 29101568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.